Evidence map›Paper›PMID 36036879›Full record

ReviewEndocrine2022

Environmental disruptors and testicular cancer.

Fabiana Faja, Sandro Esteves, Francesco Pallotti, Gaia Cicolani, Silvia Di Chiano, Enrico Delli Paoli, Andrea Lenzi, Francesco Lombardo, Donatella Paoli

Open access · hybridAbstract readReview
In one paragraph

Review in Endocrine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Exosomal ncRNAs in reproductive cancers†.Biology of reproduction · 2025
    Review
  8. Review
  9. Article
  10. EAVLD 2024 - 7Italian journal of food safety · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Male infertility.Nature reviews. Disease primers · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Fabiana FajaLaboratory of Seminology-Sperm Bank "Loredana Gandini", Department of Experimental Medicine, "Sapienza" Università di Roma, Rome, Italy.ORCID 0000-0002-5297-2448
Sandro EstevesAndrology and Human Reproduction Clinic, Av. Dr. Heitor Penteado, 1464, Campinas, Brazil.ORCID 0000-0002-1313-9680
Francesco PallottiLaboratory of Seminology-Sperm Bank "Loredana Gandini", Department of Experimental Medicine, "Sapienza" Università di Roma, Rome, Italy.ORCID 0000-0001-6042-6474
Gaia CicolaniLaboratory of Seminology-Sperm Bank "Loredana Gandini", Department of Experimental Medicine, "Sapienza" Università di Roma, Rome, Italy.ORCID 0000-0003-4629-5222
Silvia Di ChianoLaboratory of Seminology-Sperm Bank "Loredana Gandini", Department of Experimental Medicine, "Sapienza" Università di Roma, Rome, Italy.ORCID 0000-0001-6291-1887
Enrico Delli PaoliLaboratory of Seminology-Sperm Bank "Loredana Gandini", Department of Experimental Medicine, "Sapienza" Università di Roma, Rome, Italy.ORCID 0000-0003-4866-7130
Andrea LenziLaboratory of Seminology-Sperm Bank "Loredana Gandini", Department of Experimental Medicine, "Sapienza" Università di Roma, Rome, Italy.ORCID 0000-0002-7711-0465
Francesco LombardoLaboratory of Seminology-Sperm Bank "Loredana Gandini", Department of Experimental Medicine, "Sapienza" Università di Roma, Rome, Italy.ORCID 0000-0002-6943-2966
Donatella PaoliLaboratory of Seminology-Sperm Bank "Loredana Gandini", Department of Experimental Medicine, "Sapienza" Università di Roma, Rome, Italy. donatella.paoli@uniroma1.it.ORCID 0000-0002-9699-8703
Sapienza University of Rome · ITAarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTesticular cancer (TC) is the most common malignancy among young adult males. The etiology is multifactorial, and both environmental and genetic factors play an essential role in the origin and development of this tumor. In particular, exposure to environmental endocrine disruptors (EEDs), resulting from industrialization and urbanization, seems crucial both in pre-and postnatal life. However, the lack of long-term studies on a wide caseload and the difficulty in evaluating their toxic effects in vivo make it challenging to establish a causal link. This review aims to discuss the main human epidemiological studies currently available in the literature to define a possible association between these chemicals and TC.

methodsA comprehensive Medline/PubMed and Embase search was performed, selecting all relevant, peer-reviewed papers in English published from 2002 to January 2022. Other relevant papers were selected from the reference lists.

resultsTo date, literature evidence is limited due to the scarcity and heterogeneity of human studies and shows controversial data, highlighting the complexity of the topic. However, most human epidemiological studies seem to point toward a correlation between EEDs exposure and TC.

conclusionAlthough the molecular mechanisms are not yet fully understood, the role of EEDs in TC onset is plausible, but several factors, such as the individual genetic background, the exposure time, and the complex mechanism of action of these chemicals, do not allow defining the causal link with certainty and make further studies necessary to investigate this complex topic.

Indexed as

Endocrine DisruptorsNeoplasms, Germ Cell and EmbryonalTesticular NeoplasmsEnvironmental ExposureHumansMaleYoung AdultEndocrine DisruptorsEnvironmental endocrine disruptorsEnvironmental pollutionMale reproductive healthTesticular cancer

Identifiers

PMID36036879
PMCPMC9637059
OpenAlexW4293446391

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.